Simple Summary The microbiota can modulate immune responses and modify the
physiology of the human organism, thereby increasing infective risks and a neoplastic …

With the continuous advancements in tumor immunotherapy, researchers are actively
exploring new treatment methods. Peptide therapeutic cancer vaccines have garnered …

Cervical cancer (CC) remains a prevalent malignancy and a significant global public health
concern, primarily driven by persistent human papillomavirus (HPV) infections. The …

Objective: Cervical cancer is a common preventable cancer among African women living
with HIV (WLWH). Molecular diagnostics for high-risk human papillomavirus (HR-HPV) …

Despite the widespread availability of effective prophylactic vaccines to prevent human
papillomavirus (HPV) infection, HPV remains a major health burden. For health care …

Overexpression of HPV‐oncoproteins E6 and E7 is necessary for HPV‐driven cervical
carcinogenesis. Hence, these oncoproteins are promising disease‐specific biomarkers. We …

Background Previous studies have shown that changes in the microbial community of the
female urogenital tract are associated with Human papillomavirus (HPV) infection. However …

Human papillomavirus (HPV), a common cause of sexually transmitted diseases, may cause
warts and lead to various types of cancers, which makes it important to understand the risk …

Human papillomavirus (HPV) is considered to be one of the viral infections associated with
cancers and other diseases. HPV is detected asymptomatically in the oral mucosa. The …

Most cervical cancer cases are a result of persistent high-risk Human papillomavirus (HPV)
infections. Cervical cancer is prevalent in LMICs especially in SSA where it is second most …